Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Pediatric Neurology

Diagnostic Workup: Making Sense of Your Child's Tests

At a Glance

Diagnosing TUD deficiency syndrome usually takes more than one test. Doctors combine brain MRI, EEG, genetic testing, and targeted metabolic screening; a normal scan or uncertain genetic result does not necessarily rule out the disorder, and repeat testing may reveal new answers.

A diagnostic workup for a child with complex neurological symptoms is rarely a single test. Instead, it is a process of gathering “puzzle pieces” from imaging, electrical brain monitoring, and DNA analysis to build a complete picture of their condition [1][2].

The Diagnostic Completeness Checklist

To ensure no stone is left unturned, a complete evaluation typically includes the following “pillars” of testing:

  1. Genetic Testing (The Definitive Map):

    • Whole Exome Sequencing (WES): WES looks at the ‘coding’ regions of almost all 20,000 genes to find specific errors. While useful, it can miss repeat expansions, deep intronic variants, some structural variants, or mitochondrial variants [3][4].
    • Chromosomal Microarray (CMA): This test looks for missing or extra “chunks” of DNA, known as copy number variations (CNVs), which standard exome testing can sometimes miss [1][5].
    • Trio Testing: This involves testing the child and both parents at the same time to see if the genetic changes were inherited (autosomal recessive) or happened for the first time in the child (de novo) [6][7].

  2. Brain MRI (The Structural View):

    • Doctors look for specific shapes and sizes in the brain, particularly in the cerebellum (the balance center). Note that normal imaging does not exclude a genetic disorder.
    • Cerebellar Atrophy: This means the cerebellum is smaller than expected because it has shrunk over time. This is common in SCAR23 and TBC1D24-related disorders [8][9].
    • Cerebellar Hypoplasia: This means the cerebellum was small from birth because it didn’t fully develop [10].
    • Corpus Callosum Hypoplasia: A thin “bridge” between the two halves of the brain, often seen in severe WWOX-related cases [11][12].

  3. EEG (The Electrical View):

    • An Electroencephalogram (EEG) measures the brain’s electrical activity. A “prolonged” or “overnight” EEG is often better than a short one because it can capture activity during sleep [2].
    • Hypsarrhythmia: A very disorganized, high-voltage pattern associated with infantile epileptic spasms syndrome [11].
    • Multifocal Discharges: “Spikes” of electrical activity coming from several different areas of the brain [13][12].

  4. Metabolic Screening (Ruling Out “Mimics”):

    • Simple blood and urine tests (like plasma amino acids and urine organic acids) are part of a targeted evaluation for treatable metabolic disorders. Note that specific mimics, such as Vitamin B6-responsive epilepsy or GLUT1 deficiency, may require specialized testing, and families should never start high-dose vitamin B6 or other metabolic treatments without medical supervision [14][15].

Decoding Your Child’s Reports

Medical reports are written for other doctors, which can make them difficult for parents to read. Here are the plain-language meanings of common terms:

Technical Term What It Actually Means
Cerebellar Vermis Atrophy Shrinking of the middle “worm-like” part of the balance center [8].
Delayed Myelination The “insulation” (myelin) around the brain’s wires is developing more slowly than normal [11].
Epileptiform Discharges Electrical patterns (spikes or waves) that indicate the brain is “primed” for a seizure, but do not by themselves prove that a child has clinical seizures [16].
Background Slowing The brain’s overall electrical speed is slower than expected for the child’s age, often seen in developmental delays; can be affected by sleep, medicines, or illness [13].
Pathogenic Variant A genetic change that is proven to cause medical problems [17].
Variant of Uncertain Significance (VUS) A genetic change where the “jury is still out”—it might be the cause, or it might be a harmless natural variation. A VUS should not be used alone to guide medical management or reproductive decisions [18].

If your child’s reports contain many “VUS” results or “normal” findings despite clear symptoms, don’t lose heart. Many families require genetic re-analysis every 1–2 years as science discovers new genes and clarifies old ones [19][20].

Common questions in this guide

What tests are used to investigate TUD deficiency syndrome in a child?
Doctors may combine brain MRI, EEG, genetic testing, and targeted blood or urine tests rather than rely on one result. Genetic testing can include whole exome sequencing, chromosomal microarray, and testing the child with both parents. The best combination depends on the child’s symptoms and earlier results.
Can a normal brain MRI rule out TUD deficiency?
No. A normal MRI does not exclude a genetic disorder, because some children have symptoms without a characteristic structural pattern. MRI is used to look for findings such as a small or shrinking cerebellum and changes in the brain’s connecting structures.
What does a VUS mean on my child's genetic report?
A variant of uncertain significance, or VUS, is a DNA change that scientists cannot yet classify as harmful or harmless. It should not be used by itself to make treatment or reproductive decisions. The result may be reviewed again as new medical knowledge becomes available.
What should happen if whole exome sequencing does not find the cause?
Whole exome sequencing examines the coding parts of genes but can miss some DNA changes, including repeat expansions, changes outside the main gene instructions, larger DNA rearrangements, and mitochondrial DNA changes. The genetics team may consider chromosomal microarray, testing both parents with the child, or other testing based on the clinical picture. Periodic re-analysis can also help when new genes or evidence are discovered.
Why might my child need an overnight EEG?
An overnight or prolonged EEG records brain activity during sleep as well as wakefulness, giving doctors more time to capture abnormal patterns. It may help identify disorganized activity or spikes from more than one brain region, but an EEG finding alone does not always prove that a clinical seizure occurred.
How are treatable metabolic mimics checked?
Doctors may use blood and urine tests, such as plasma amino acids and urine organic acids, to look for some treatable metabolic conditions. Other possibilities, including vitamin B6-responsive epilepsy or GLUT1 deficiency, may require specialized tests. Do not give high-dose vitamin B6 or start another metabolic treatment without medical supervision.

Get notified when new evidence is published on Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (20)
  1. 1

    A clinical diagnostic algorithm for early onset cerebellar ataxia.

    Brandsma R, Verschuuren-Bemelmans CC, Amrom D, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2019; (23(5)):692-706 doi:10.1016/j.ejpn.2019.08.004.

    PMID: 31481303
  2. 2

    [Differential diagnosis of paroxysms of tonic muscle tension in children of early age with delay of psychomotor development and abnormal neurologic status].

    Mironov MB, Bobylova MY, Nekrasova IV, et al.

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2017; (117(6)):4-9 doi:10.17116/jnevro2017117614-9.

    PMID: 28745663
  3. 3

    Whole Exome Sequencing as a First-Line Molecular Genetic Test in Developmental and Epileptic Encephalopathies.

    Vetri L, Calì F, Saccone S, et al.

    International journal of molecular sciences 2024; (25(2)) doi:10.3390/ijms25021146.

    PMID: 38256219
  4. 4

    Clinical sequencing yield in epilepsy, autism spectrum disorder, and intellectual disability: A systematic review and meta-analysis.

    Stefanski A, Calle-López Y, Leu C, et al.

    Epilepsia 2021; (62(1)):143-151 doi:10.1111/epi.16755.

    PMID: 33200402
  5. 5

    Autosomal recessive spinocerebellar ataxia 18 caused by homozygous exon 14 duplication in GRID2 and review of the literature.

    Ceylan AC, Acar Arslan E, Erdem HB, et al.

    Acta neurologica Belgica 2021; (121(6)):1457-1462 doi:10.1007/s13760-020-01328-z.

    PMID: 32170608
  6. 6

    Intrafamilial neurological phenotypic variability due to either biallelic or monoallelic pathogenic variants in CACNA1A.

    Mammadova D, Kraus C, Leis T, et al.

    Frontiers in neurology 2024; (15()):1458109 doi:10.3389/fneur.2024.1458109.

    PMID: 39416668
  7. 7

    Developmental and epileptic encephalopathy 82 (DEE82) with novel compound heterozygous mutations of GOT2 gene.

    Çapan ÖY, Türkdoğan D, Atalay S, Çağlayan HS

    Seizure 2024; (116()):126-132 doi:10.1016/j.seizure.2023.11.003.

    PMID: 37977948
  8. 8

    Clinical and Molecular Spectrum of Autosomal Recessive CA8-Related Cerebellar Ataxia.

    Kaiyrzhanov R, Ortigoza-Escobar JD, Stringer BW, et al.

    Movement disorders : official journal of the Movement Disorder Society 2024; (39(6)):983-995 doi:10.1002/mds.29754.

    PMID: 38581205
  9. 9

    Intrafamilial phenotypic variability in TBC1D24-TLDc homozygous pathogenic variant-related developmental and epileptic encephalopathy.

    Lee HF, Chi CS, Tsai CR

    Clinical neurology and neurosurgery 2022; (214()):107142 doi:10.1016/j.clineuro.2022.107142.

    PMID: 35149262
  10. 10

    Cerebellar atrophy in genetic epileptic encephalopathies: A cohort study and a systematic review.

    Yang YL, Lee HF, Chi CS, et al.

    Seizure 2024; (120()):41-48 doi:10.1016/j.seizure.2024.06.013.

    PMID: 38897163
  11. 11

    WWOX-related developmental and epileptic encephalopathy (WOREE): A case series of seven patients from Argentina.

    Guevara J, Touzon MS, Negrete S, et al.

    Seizure 2026; (142()):204-211 doi:10.1016/j.seizure.2026.08.027.

    PMID: 42721537
  12. 12

    WWOX developmental and epileptic encephalopathy: Understanding the epileptology and the mortality risk.

    Oliver KL, Trivisano M, Mandelstam SA, et al.

    Epilepsia 2023; (64(5)):1351-1367 doi:10.1111/epi.17542.

    PMID: 36779245
  13. 13

    [Clinical features of epilepsy in 5 children with Mowat-Wilson syndrome].

    Ju Y, Ji TY

    Zhonghua er ke za zhi = Chinese journal of pediatrics 2022; (60(6)):578-582 doi:10.3760/cma.j.cn112140-20220316-00210.

    PMID: 35658366
  14. 14

    Testing for Inborn Errors of Metabolism.

    Kwon JM

    Continuum (Minneapolis, Minn.) 2018; (24(1, Child Neurology)):37-56 doi:10.1212/CON.0000000000000563.

    PMID: 29432236
  15. 15

    Brief Report: Delayed Diagnosis of Treatable Inborn Errors of Metabolism in Children with Autism and Other Neurodevelopmental Disorders.

    Márquez-Caraveo ME, Ibarra-González I, Rodríguez-Valentín R, et al.

    Journal of autism and developmental disorders 2021; (51(6)):2124-2131 doi:10.1007/s10803-020-04682-2.

    PMID: 32880084
  16. 16

    [Clinical and genetic characteristics of children with STXBP1 encephalopathy].

    Cao JJ, Ji XN, Mao YY, et al.

    Zhonghua er ke za zhi = Chinese journal of pediatrics 2020; (58(6)):493-498 doi:10.3760/cma.j.cn112140-20191028-00683.

    PMID: 32521962
  17. 17

    A diagnostic ceiling for exome sequencing in cerebellar ataxia and related neurological disorders.

    Ngo KJ, Rexach JE, Lee H, et al.

    Human mutation 2020; (41(2)):487-501 doi:10.1002/humu.23946.

    PMID: 31692161
  18. 18

    Precision Medicine in Epilepsy: Diagnostic Yield by Next-Generation Sequencing and Genotype-Phenotype Findings in a Romanian Cohort.

    Butnariu LI, Grigore E, Schreiner TG, et al.

    International journal of molecular sciences 2026; (27(19)) doi:10.3390/ijms27198878.

    PMID: 42884121
  19. 19

    Genetic diagnoses in epilepsy: The impact of dynamic exome analysis in a pediatric cohort.

    Rochtus A, Olson HE, Smith L, et al.

    Epilepsia 2020; (61(2)):249-258 doi:10.1111/epi.16427.

    PMID: 31957018
  20. 20

    Exome sequencing for patients with developmental and epileptic encephalopathies in clinical practice.

    Scheffer IE, Bennett CA, Gill D, et al.

    Developmental medicine and child neurology 2023; (65(1)):50-57 doi:10.1111/dmcn.15308.

    PMID: 35701389

This page explains diagnostic testing for a child with suspected TUD deficiency syndrome for informational purposes only and does not constitute medical advice. Your child's pediatric neurology and genetics teams should interpret the results and recommend next steps.

Guide contents Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency
Research & Literature
03 Genetics, Biology, and Look-Alike Conditions 05 Treatment Strategy and Daily Management